Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment

Schoeppe, Robert and Babl, Nathalie and Decking, Sonja-Maria and Schoenhammer, Gabriele and Siegmund, Andreas and Bruss, Christina and Dettmer, Katja and Oefner, Peter J. and Frick, Linus and Weigert, Anna and Jantsch, Jonathan and Herr, Wolfgang and Rehli, Michael and Renner, Kathrin and Kreutz, Marina (2023) Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment. FRONTIERS IN ONCOLOGY, 13: 1120194. ISSN 2234-943X,

Full text not available from this repository. (Request a copy)

Abstract

IntroductionGlutamine deficiency is a well-known feature of the tumor environment. Here we analyzed the impact of glutamine deprivation on human myeloid cell survival and function. MethodsDifferent types of myeloid cells were cultured in the absence or presence of glutamine and/or with L-methionine-S-sulfoximine (MSO), an irreversible glutamine synthetase (GS) inhibitor. GS expression was analyzed on mRNA and protein level. GS activity and the conversion of glutamate to glutamine by myeloid cells was followed by 13C tracing analyses. ResultsThe absence of extracellular glutamine only slightly affected postmitotic human monocyte to dendritic cell (DC) differentiation, function and survival. Similar results were obtained for monocyte-derived macrophages. In contrast, proliferation of the monocytic leukemia cell line THP-1 was significantly suppressed. While macrophages exhibited high constitutive GS expression, glutamine deprivation induced GS in DC and THP-1. Accordingly, proliferation of THP-1 was rescued by addition of the GS substrate glutamate and 13C tracing analyses revealed conversion of glutamate to glutamine. Supplementation with the GS inhibitor MSO reduced the survival of DC and macrophages and counteracted the proliferation rescue of THP-1 by glutamate. DiscussionOur results show that GS supports myeloid cell survival in a glutamine poor environment. Notably, in addition to suppressing proliferation and survival of tumor cells, the blockade of GS also targets immune cells such as DCs and macrophages.

Item Type: Article
Uncontrolled Keywords: METABOLISM; DEGRADATION; MACROPHAGES; INHIBITION; PHENOTYPE; CULTURE; TUMORS; dendritic cells; glutamine; macrophages; glutamine synthetase; glutamate
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Medicine > Institut für Funktionelle Genomik > Lehrstuhl für Funktionelle Genomik (Prof. Oefner)
Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Medicine > Zentren des Universitätsklinikums Regensburg > Regensburger Centrum für Interventionelle Immunologie (RCI)
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Plastische-, Hand- und Wiederherstellungschirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 07 Mar 2024 10:56
Last Modified: 07 Mar 2024 11:01
URI: https://pred.uni-regensburg.de/id/eprint/58874

Actions (login required)

View Item View Item